Results 121 to 130 of about 11,390 (207)

Olmesartan-related sprue-like enteropathy presenting as severe diarrhoea. [PDF]

BMJ Case Rep
Suardi S, Vicardi M, Spillere C, Leidi P, Pecori S, Campagnola P, Friso S, Martinelli N.   +7 more
europepmc   +1 more source

An In Silico and In Vitro Approach Identified Potential Trypanothione Synthetase Inhibitors with Trypanocidal Activity. [PDF]

Molecules
Gómez-Escobedo R, Méndez-Álvarez D, Paz-González AD, Ortiz-Pérez E, Vázquez-Jiménez LK, Martínez-Vázquez AV, Delgado-Maldonado T, Quintero-Solano JM, Vázquez C, Saavedra E, Avalos-Navarro G, Vázquez K, Rivera G, Nogueda-Torres B.   +13 more
europepmc   +1 more source

Rapid Normalization of Amniotic Fluid Index Following Discontinuation of Olmesartan: A Case Report. [PDF]

AJP Rep
Van Oosbree A, Larson T, Conley H, Bridges M, Argoti P, Mari G.   +5 more
europepmc   +1 more source

Serine encodes drug selectivity in human OAT1. [PDF]

Structure
Dai Y, Lee CH.
europepmc   +1 more source

Stability of Olmesartan Medoxomil Tablets in Unit-Dose Packaging With Metformin Hydrochloride Tablets. [PDF]

Cureus
Ohashi R, Yasunaga S, Ishimura A, Furuya T, Aizawa Y, Omori T, Kurita T, Nakajima T, Takizawa Y.   +8 more
europepmc   +1 more source

Chronic plateau exposure attenuates antihypertensive efficacy in highlanders: insights from the OMAN trial. [PDF]

J Hypertens
Zuo X, Zhang X, Ye R, Sun L, Liu X, Xu M, Yang X, Jia S, Liu H, Chen X.   +9 more
europepmc   +1 more source

Development and Evaluation of a Modified Fixed-Dose Combination Antihypertensive Tablet Containing S-Amlodipine Besylate: A Bioequivalence and Stability Study. [PDF]

Pharmaceutics
Moon HW, Jeong JH, Park CW.
europepmc   +1 more source

A case of adrenal insufficiency after initiation of targeted-release budesonide formulation (Nefecon) in a patient with IgA nephropathy. [PDF]

Clin Kidney J
Laxamana TD, Fervenza FC, Glassock RJ, Zand L.   +3 more
europepmc   +1 more source

Zilebesiran: an RNA interference agent-its need and potential to transform hypertension treatment. [PDF]

Egypt Heart J
Verma S, Pradhan A, Thandi P.
europepmc   +1 more source

Safety and efficacy of triple combination therapy in hypertension and dyslipidemia: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Egypt Heart J
Shaban AY, Hassan A, Eltawansy S, Hassan MA, Desouki MT, Ahmed N, Badr S, Elgendy AY, Nassar M, Hakim D.   +9 more
europepmc   +1 more source